Your browser doesn't support javascript.
loading
Second nationwide surveillance of bacterial pathogens in patients with acute uncomplicated cystitis conducted by Japanese Surveillance Committee from 2015 to 2016: antimicrobial susceptibility of Escherichia coli, Klebsiella pneumoniae, and Staphylococcus saprophyticus.
Hayami, Hiroshi; Takahashi, Satoshi; Ishikawa, Kiyohito; Yasuda, Mitsuru; Yamamoto, Shingo; Wada, Koichiro; Kobayashi, Kanao; Hamasuna, Ryoichi; Minamitani, Shinichi; Matsumoto, Tetsuya; Kiyota, Hiroshi; Tateda, Kazuhiro; Sato, Junko; Hanaki, Hideaki; Masumori, Naoya; Nishiyama, Hiroyuki; Miyazaki, Jun; Fujimoto, Kiyohide; Tanaka, Kazushi; Uehara, Shinya; Matsubara, Akio; Ito, Kenji; Hayashi, Kenji; Kurimura, Yuichiro; Ito, Shin; Takeuchi, Toshimi; Narita, Harunori; Izumitani, Masanobu; Nishimura, Hirofumi; Kawahara, Motoshi; Hara, Makoto; Hosobe, Takahide; Takashima, Kenji; Chokyu, Hirofumi; Matsumura, Masaru; Ihara, Hideari; Uno, Satoshi; Monden, Koichi; Sumii, Toru; Kawai, Shuichi; Kariya, Satoru; Sato, Takashi; Yoshioka, Masaru; Kadena, Hitoshi; Matsushita, Shinji; Nishi, Shohei; Hosokawa, Yukinari; Shirane, Takeshi; Yoh, Mutsumasa; Watanabe, Syuji.
Afiliação
  • Hayami H; The Urogenital Sub-committee and the Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Diseases (JAID and the Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan; Blood Purification Center, Kagoshima University Hospital, Kagoshima,
  • Takahashi S; The Urogenital Sub-committee and the Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Diseases (JAID and the Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan; Department of Infection Control and Laboratory Medicine, Sapporo Medi
  • Ishikawa K; The Urogenital Sub-committee and the Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Diseases (JAID and the Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan; Department of Urology, School of Medicine, Fujita Health University,
  • Yasuda M; The Urogenital Sub-committee and the Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Diseases (JAID and the Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan; Department of Urology, Gifu University Hospital, Gifu, Japan.
  • Yamamoto S; The Urogenital Sub-committee and the Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Diseases (JAID and the Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan; Department of Urology, Hyogo College of Medicine, Hyogo, Japan.
  • Wada K; The Urogenital Sub-committee and the Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Diseases (JAID and the Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan; Department of Urology, Okayama University Graduate School of Medicine
  • Kobayashi K; The Urogenital Sub-committee and the Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Diseases (JAID and the Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan; Department of Urology, Chugoku Rosai Hospital, Hiroshima, Japan.
  • Hamasuna R; The Urogenital Sub-committee and the Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Diseases (JAID and the Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan; Department of Urology, University of Occupational and Environmental H
  • Minamitani S; The Urogenital Sub-committee and the Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Diseases (JAID and the Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan; Daiichi Sankyo Co., Ltd, Japan.
  • Matsumoto T; The Surveillance Committee of JSC, JAID and JSCM, Tokyo, Japan.
  • Kiyota H; The Surveillance Committee of JSC, JAID and JSCM, Tokyo, Japan; Department of Urology, The Jikei University Katsushika Medical Center, Tokyo, Japan.
  • Tateda K; The Surveillance Committee of JSC, JAID and JSCM, Tokyo, Japan.
  • Sato J; The Surveillance Committee of JSC, JAID and JSCM, Tokyo, Japan.
  • Hanaki H; Infection Control Research Center, Kitasato University, Tokyo, Japan.
  • Masumori N; Department of Urology, Sapporo Medical University School of Medicine, Hokkaido, Japan.
  • Nishiyama H; Department of Urology, University of Tsukuba, Ibaraki, Japan.
  • Miyazaki J; Department of Urology, University of Tsukuba, Ibaraki, Japan.
  • Fujimoto K; Department of Urology, Nara Medical University, Nara, Japan.
  • Tanaka K; Division of Urology, Department of Surgery Related Faculty of Medicine, Kobe University Graduate School of Medicine, Hyogo, Japan.
  • Uehara S; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
  • Matsubara A; Department of Urology, Institute of Biomedical & Health Sciences, Hiroshima University, Hiroshima, Japan.
  • Ito K; Ito Urology Clinic, Fukuoka, Japan.
  • Hayashi K; Tomakomai Urology and Cardiology Clinic, Hokkaido, Japan.
  • Kurimura Y; Tomakomai Urology and Cardiology Clinic, Hokkaido, Japan.
  • Ito S; iClinic, Miyagi, Japan.
  • Takeuchi T; Takeuchi Urology and Dermatology Clinic, Gifu, Japan.
  • Narita H; Narita Clinic, Aichi, Japan.
  • Izumitani M; Izumitani Fureai Clinic, Aichi, Japan.
  • Nishimura H; Nishimura Urology Clinic, Fukuoka, Japan.
  • Kawahara M; Kawahara Urology Clinic, Kagoshima, Japan.
  • Hara M; Department of Urology, Tsujinaka Hospital Kashiwanoha, Chiba, Japan.
  • Hosobe T; Hosobe Clinic, Tokyo, Japan.
  • Takashima K; Takashima Urology Clinic, Nara, Japan.
  • Chokyu H; Cyokyu Tenma Clinic, Hyogo, Japan.
  • Matsumura M; Matsumura Urology Clinic, Hyogo, Japan.
  • Ihara H; Ihara Clinic, Hyogo, Japan.
  • Uno S; Hirajima Clinic, Okayama, Japan.
  • Monden K; Araki Urological Clinic, Okayama, Japan.
  • Sumii T; Sumii Clinic, Hiroshima, Japan.
  • Kawai S; Kawai Urology Clinic, Fukuoka, Japan.
  • Kariya S; Ootemachi Clinic, Kagoshima, Japan.
  • Sato T; Nissin Urological Clinic, Hokkaido, Japan.
  • Yoshioka M; Yoshioka Urology Clinic, Hyogo, Japan.
  • Kadena H; Kadena Urological Clinic, Hiroshima, Japan.
  • Matsushita S; Department of Urology, Kagoshima Prefectural Ohshima Hospital, Kagoshima, Japan.
  • Nishi S; Nishi Urology and Dermatology Clinic, Fukuoka, Japan.
  • Hosokawa Y; Department of Urology, Tane General Hospital, Osaka, Japan.
  • Shirane T; Shirane Urology Clinic, Hiroshima, Japan.
  • Yoh M; Yoh Urology and Dermatology Clinic, Aichi, Japan.
  • Watanabe S; Department of Urology, Saiseikai Chuwa Hospital, Nara, Japan.
J Infect Chemother ; 25(6): 413-422, 2019 Jun.
Article em En | MEDLINE | ID: mdl-30905628

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cistite / Farmacorresistência Bacteriana Múltipla / Escherichia coli / Staphylococcus saprophyticus / Klebsiella pneumoniae / Antibacterianos Tipo de estudo: Clinical_trials / Guideline / Screening_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: J Infect Chemother Assunto da revista: MICROBIOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cistite / Farmacorresistência Bacteriana Múltipla / Escherichia coli / Staphylococcus saprophyticus / Klebsiella pneumoniae / Antibacterianos Tipo de estudo: Clinical_trials / Guideline / Screening_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: J Infect Chemother Assunto da revista: MICROBIOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2019 Tipo de documento: Article